Wegovy is a registered trademark of Novo Nordisk A/S. It is an FDA-approved prescription medicine, and a licensed clinician decides whether it is appropriate for a patient.
There is no single Blue Cross Blue Shield answer to a coverage question, because Blue Cross Blue Shield is not a single company. It is a group of independent, locally operated companies that each license the name and run their own plans. Two members with similar looking cards can have very different drug benefits.
This page is general information, not medical advice. Talk to a licensed clinician about your situation.
Risk information first
Wegovy carries a boxed warning about the risk of thyroid C-cell tumors. In rodent studies, semaglutide caused thyroid C-cell tumors. It is not known whether it causes these tumors, including medullary thyroid carcinoma, in people.
It should not be used by anyone with a personal or family history of medullary thyroid carcinoma, or by anyone with Multiple Endocrine Neoplasia syndrome type 2. Serious risks described in the labeling include inflammation of the pancreas, gallbladder problems, low blood sugar, kidney injury, serious allergic reactions, suicidal behavior or thinking, and changes in vision in people with type 2 diabetes. Nausea, vomiting, diarrhea, and constipation are commonly reported.
Read the official Wegovy Prescribing Information and Medication Guide for the complete boxed warning, contraindications, warnings, and adverse reactions. Whether a plan pays is a separate question from whether a medicine is right for you, and only a clinician can answer the second one.
Why there is no single answer
Three layers sit between the brand on your card and your actual benefit.
The first layer is which local company issued your plan. Each operates in its own service area with its own formularies and its own medical policies.
The second layer is your plan sponsor. If your coverage comes through an employer, that employer chose a benefit package, and weight-management medicines are a category an employer can include or leave out. Many larger employers pay claims themselves and hire the insurer to administer the plan, which gives the employer even more say over what is covered.
The third layer is the product type. Coverage bought on your own through the individual market, coverage through an employer, a plan for federal employees, and a Medicare or Medicaid product each follow different rules, even when they carry the same name.
That is why a forum post from someone in another state, or even a coworker on a different plan tier, tells you nothing reliable about your own benefit.
Find your own plan first
Look at your member card. Note the plan name, the group number, and the prefix printed before your member ID. Those identify which local company administers your benefits and which group you belong to. The member services number on the back is the right number to call, not a national line you found in a search.
Then log in to the member portal for that specific plan. You are looking for the pharmacy or drug benefit section, not the medical benefit section.
The three documents to pull
The current year formulary. Search it for the exact product name. Note the tier and every symbol beside the entry. Those symbols usually flag prior authorization, step therapy, or a quantity limit. Confirm the year, because formularies are revised at renewal.
Your summary of benefits. This shows your deductible, your cost share by tier, and your out-of-pocket maximum, which determines what you would actually pay at a given point in the plan year.
The plan's clinical policy or coverage criteria. When a plan requires review before it will pay, it publishes what it wants documented. Reading that before the request is submitted is the most effective way to avoid a delay.
Questions for the member services call
Ask whether the product is on your current formulary and on what tier. Ask which requirements apply, such as prior authorization, step therapy, or quantity limits. Ask what your cost share would be at an in-network pharmacy and whether your deductible currently applies. Ask whether a particular pharmacy or mail service is preferred.
Ask one more question that people often skip. Ask whether weight-management medicines are excluded from your group's benefit entirely, because an exclusion is a different problem from a clinical review, and it sends you to a different place for help.
Write down the date and the representative's name. If a prescription already exists, ask an in-network pharmacy to process or estimate the claim, since a processed claim is the clearest answer available.
Exclusion, review, or denial
If the category is excluded, the conversation moves to your employer. Human resources or your benefits administrator can tell you whether a formulary exception process exists for your group.
If a review is required, your clinician submits documentation and the plan measures it against its own criteria. Incomplete submissions are a common cause of delay, so confirm exactly which records and forms are wanted. Approvals are often granted for a limited period, so note the end date and begin the renewal early.
If a request is denied, ask for the reason in writing. The notice must explain your appeal rights and the deadline. Your clinician may be able to add information or request a review, though an appeal does not assure a different result.
Where Body Good fits
Body Good provides clinical and administrative services. A licensed clinician reviews your history and decides what is appropriate. A program can include follow-up, coverage support, and routing a prescription to a state-licensed pharmacy.
Coverage support means running a benefit check and helping prepare the paperwork your plan requests. It is assistance with the process only. Approval and payment are determined by your plan, not by Body Good. Be cautious of any service that suggests it can deliver an approval.
Body Good's prices are service fees for the program described during intake. They are not the price of medication, and the cost of medication is separate and not included. They are not a quote for any individual, and eligibility is determined by a clinician.
This website is an information and pricing overview. It takes no payment, collects no protected health information, and hosts no intake form. Intake and checkout take place on joinbodygood.com.
If your plan does not pay
Ask about self-pay routes. Novo Nordisk publishes current savings and patient-support terms through its official channels, including NovoCare. Programs carry eligibility rules, maximum benefits, and end dates, and people in government programs are often excluded, so read the current terms rather than an advertisement.
Ask your plan whether a cash payment counts toward your deductible or out-of-pocket maximum. Often it does not.
Then return to the clinical question and ask your clinician what else is appropriate for you. Cost is a real constraint, but it is not a treatment plan.
Frequently asked questions
Is there one Blue Cross Blue Shield drug list?
No. Independent local companies each maintain their own formularies, and employer groups can add their own terms. Use the drug list published for your specific plan and plan year.
My coworker was approved and I was not. Why?
Approvals follow each plan's own criteria and each person's documented clinical picture. Different groups, different tiers, and different submitted records all produce different outcomes.
Can Body Good check my benefits for me?
Body Good can run a benefit check and help with the paperwork your plan requests. The plan makes the decision. Begin the secure intake to provide information for clinical review.
Body Good is not affiliated with, endorsed by, or sponsored by the Blue Cross Blue Shield Association or any of its licensee companies, and Blue Cross and Blue Shield are marks of the Blue Cross Blue Shield Association.
Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Body Good is not affiliated with, endorsed by, sponsored by, or authorized by Eli Lilly and Company or Novo Nordisk A/S. All trademarks are the property of their respective owners.